Erichsenborg2346

This article is protected by copyright. Inflammation inhibitor All rights reserved. This article is protected by copyright. All rights reserved.Semiconductor oxides of bismuth and zinc have been synthesized using modified sol-gel method and sol-combustion method, respectively. The synthesized catalysts were characterized by X-ray powder diffraction (XRD), field emission scanning electron microscopy (FESEM), energy dispersive X-rays spectroscopy (EDS), X-ray photoelectron spectroscopy (XPS) and UV-vis spectroscopy. The photocatalytic activity of Bi2 O3 and ZnO was evaluated for the degradation of Alizarin Red S (ARS), as a model pollutant, at 20 mg/l level in water under visible light irradiation. The percentage of photocatalytic degradation was determined using UV-vis spectrophotometer. The photocatalytic results revealed that Bi2 O3 and ZnO could effectively degrade 73% and 53% of ARS, respectively within 13 hours under visible light illumination, indicating that synthesized Bi2 O3 is a better photocatalyst than ZnO. Photodegradation of ARS with Bi2 O3 and ZnO is remarkably influenced by change in pH of the dye solution and pH 8 was found to be the most favourable for maximum removal of ARS in case of both Bi2 O3 (75%) and ZnO (58%) photocatalyst. This article is protected by copyright. All rights reserved.AIMS AND OBJECTIVES To explore the health care professional experience of providing care coordination to people living with multimorbidity. BACKGROUND There is increasing interest in improving care of people living with multimorbidity who need care coordination to help manage their health. Little is known about the experiences of health care professionals working with people living with multimorbidity. DESIGN Phenomenological approach to understanding the experiences of health care professionals. METHODS We interviewed 18 health care professionals, including 11 registered nurses, working in care coordination in Melbourne, Australia. We used interpretative phenomenological analysis to identify themes from descriptions of providing care, identifying and responding to a person's needs, and the barriers and facilitators to providing person-centred care. RESULTS We identified four themes (1) Challenge of focusing on the person; (2) 'Hear their story', listening to and giving time to clients to tell their story; (3) Strategies for engagement in the program; and, (4) 'See the bigger picture', looking beyond the disease to the needs of a person. Our results are reported using COREQ. CONCLUSIONS The health care professionals experienced challenges to a traditional approach to care when focusing on the person. They described providing care that was person-centred, and acknowledged that optimal, guideline-oriented care might not be achieved. They took the necessary time to hear the story and see the context of the person's life, to help the person manage their health. RELEVANCE TO CLINICAL PRACTICE For registered nurses in care coordination programs, focusing on the client may challenge traditional approaches to care. Providing care involves developing a relationship with the client to optimise health outcomes. Experienced registered nurses appear to use skills in reflective practice, and accept the parameters of care to improve the client's health and wellbeing. This article is protected by copyright. All rights reserved.The LACE+ (Length of stay, Acuity of admission, Charlson Comorbidity Index score, and Emergency department visits in the past 6 months) risk-prediction tool has never been tested in an orthopedic surgery population. LACE+ may help physicians more effectively identify and support high-risk orthopedics patients after hospital discharge. LACE+ scores were retrospectively calculated for all consecutive orthopedic surgery patients (n = 18 893) at a multi-center health system over 3 years (2016-2018). Coarsened exact matching was employed to create "matched" study groups with different LACE+ score quartiles (Q1, Q2, Q3, Q4). Outcomes were compared between quartiles. In all, 1444 patients were matched between Q1 and Q4 (n = 2888); 2079 patients between Q2 and Q4 (n = 4158); 3032 patients between Q3 and Q4 (n = 6064). Higher LACE+ scores significantly predicted 30D readmission risk for Q4 vs Q1 and Q4 vs Q3 (P  less then  .001). Larger LACE+ scores also significantly predicted 30D risk of ED visits for Q4 vs Q1, Q4 vs Q2, and Q4 vs Q3 (P  less then  .001). Increased LACE+ score also significantly predicted 30D risk of reoperation for Q4 vs Q1 (P = .018), Q4 vs Q2 (P  less then  .001), and Q4 vs Q3 (P  less then  .001). © 2020 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.Heart transplantation guidelines recommend against matching donors with significant weight but not height discrepancies. This study analyzed the impact of donor-recipient height mismatch on mortality among heart transplant recipients. We retrospectively analyzed all adult patients in the United Network for Organ Sharing (UNOS) registry undergoing heart transplantation from 1990 to September 2016. Moderate and severe height mismatch were classified as >10% and >15% difference in donor height from recipient height, respectively. The primary outcome was one-year mortality. Adjusted Cox hazards regression was performed, and Kaplan-Meier estimates illustrated 10-year survival. Of 44,877 transplants, 4,822 (10.7%) were moderately height mismatched. Height mismatched recipients were more frequently female (41.6 vs. 21.8%, p less then 0.001), sex mismatched (53.8 vs. 24.9%, p less then 0.001), and weight mismatched (4.9 vs. 1.9%, p less then 0.001). After adjustment, recipients of moderately (HR=1.15 [1.02-1.30]) and severely (HR=1.38 [1.10-1.74]) taller donor hearts were at increased risk of mortality at one year relative to height-matched recipients. Furthermore, of 1,042 (21.6%) severe mismatches, recipients with taller (HR=1.39 [1.11-1.74]) but not shorter (HR=0.79 [0.44-1.43]) donors faced increased 10-year mortality. The effect was pronounced among re-transplant candidates (HR=1.96 [1.07-3.59]). In conclusion, matching with moderately or severely taller donors is an independent predictor of mortality among primary and re-transplant candidates. This article is protected by copyright. All rights reserved.